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http://dxObjectives: Recent advances in airway transplantation have shown the ability of ex vivo or in vivo tracheal regen-
eration with bioengineered conduits or biological substitutes, respectively. Previously, we established a process of
in vivo–guided tracheal regeneration using vascular allografts as a biological scaffold. We theorized that tracheal
healingwas the consequenceof amixedphenomenon associating tracheal contraction and regeneration.Theaimof
the present study was to determine the role that bone marrow stem cells play in that regenerative process.
Methods: Three groups of 12 rabbits underwent a gender-mismatched aortic graft transplantation after tracheal
resection. The first group received no cells (control group), the second group had previously received autologous
green fluorescent protein–labeled mesenchymal stem cell transplantation, and the third group received 3 labeled
mesenchymal stem cell injections on postoperative days 0, 10, and 21.
Results: The clinical results were impaired by stent complications (obstruction ormigration), but no anastomotic
leakage, dehiscence, or stenosis was observed. The rabbits were killed, and the tracheawas excised for analysis at
1 to 18 months after tracheal replacement. In all 3 groups, microscopic examination showed an integrated aortic
graft lined bymetaplastic epithelium. By 12months, immature cartilagewas detected among disorganized elastic
fibers. Positive SRY gene detection served as evidence for engraftment of cells derived from the male recipient.
EF-green fluorescent protein detection showed bone marrow–derived mesenchymal stem cell involvement.
Conclusions: The results of the present study imply a role for bone marrow stem cells in tracheal regeneration
after aortic allografting. Studies are necessary to identify the local and systemic factors stimulating that regen-
erative process. (J Thorac Cardiovasc Surg 2013;145:1297-304)G
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The Journal of Thoracic and CarMost organs are transplantable, but airway transplantation
remains an exception, in large part because of the complex-
ity of the structure, the lack of a viable scaffold, and a need
for continuous patency. To date, few have overcome these
many hurdles to tracheal replacement.1-3 As recognized by
Bader and Macchiarini,4 who transplanted the first tissue-
engineered trachea in 2008: ‘‘Currently, engineering a 3D
[3-dimensional] construct such as a trachea or other tissues
is complicated not only from the cell biology point of view:
the organizational efforts of tissue engineering are indeed
formidable.’’ One potential solution to this is in vivo–guided
tissue regeneration or rebuilding the trachea in situ. Doing
so, likewise requires a transplantable scaffold and appropri-
ate cells for cartilage reconstruction and an epithelial lining.
Previously, we reported that an aortic allograft segment
could be a valuable tracheal scaffold in a sheep model.5-7
More recently, these results have been confirmed in
a pig model.8,9 In those studies, we observed a re-
epithelialization of the graft and newly formed rings of car-
tilage, consistent with tracheal regeneration. Hypothesizing
the participation of recipient stem cells in the regeneration
of a patent, cartilaginous, lined construct, we scaled down to
a rabbit model, which was easier to work with for technical
reasons, to assess whether bone marrow-derived mesenchy-
mal stem cells (MSCs) were involved. To test this, we
transplanted autologous-labeled MSCs to verify bone
marrow involvement or injected autologous labeled MSCsdiovascular Surgery c Volume 145, Number 5 1297
Abbreviations and Acronyms
GFP ¼ green fluorescent protein
MSCs ¼ mesenchymal stem cells
PBS ¼ phosphate-buffered saline
PCR ¼ polymerase chain reaction
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All rabbits underwent tracheal replacement by aortic allo-
graft as previously described.5-7 The labeled cells were
therefore tracked in the allograft after explantation.
METHODS
Gender-mismatched tracheal replacement with a fresh female aortic al-
lograft was performed on 34 male New Zealand white adult-size rabbits.
All experiments were conducted in accordance with the Guide for the
Care and Use of Laboratory Animals (National Institutes of Health publi-
cation no. 86-23, revised 1996) and under study protocols approved by the
Institutional Animal Care and Use Committee at the University of
Minnesota.
Experimental Design
The rabbits were assigned to 1 of the 3 following groups: group 1, tra-
cheal replacement alone (n ¼ 12); group 2, autologous green fluorescent
protein (GFP)-labeled MSC transplantation and tracheal replacement 3
months later (n ¼ 12); and group 3, tracheal replacement and autologous
GFP-labeled MSC injections on postoperative days 0, 10, and 21 (n ¼ 12).
Cell Culture
Autologous bone marrow harvest and stem cell culture.
Under anesthesia, bone marrow was harvested from the iliac crest. The as-
pirate was centrifuged, bone marrow mononuclear cells isolated, and red
blood cells destroyed using red blood cell lysis buffer. After suspension
and washing with phosphate-buffered saline (PBS), the cells were cultured
in LTCmedia containing a-minimum essential medium (Invitrogen, Carls-
bad, Calif), 12,5% horse serum (Invitrogen), 12,5% fetal bovine serum
(Hyclone, Logan, Utah), 1 mM hydrocortisone (Sigma-Aldrich, St. Louis,
Mo), 5 mM b-mercaptoethanol (Invitrogen), 50 U/mg penicillin/streptomy-
cin (Invitrogen), and 0.25 mg/mL amphotericin B (Invitrogen). Nonadher-
ent cells were removed by washing at 48 hours; adherent cells were
cultured, with the medium replaced every 2 days. After 15 days of primary
culture, individual colonies had formed. When 80% confluence of cells
was achieved, the cells were trypsinized and passaged every 5 days. During
the culture period, no cell morphologic alteration occurred. Typical pri-
mary or passaged MSCs displayed fibroblast-like morphologic features.
The MSCs were positive for CD29 but negative for CD45.
Retroviral vector, virus production, and transfection of
MSCs. Recombinant lentiviruses expressing GFP were generated using
the 3-plasmid system by cotransfection of 293T cells. Then, MSCs were
exposed to viral supernatant containing EF-GFP virus (titer used 1 3 106
transducing units needed/mL) in the presence of 8 mg/mL polybrene for
24 hours, as described by Cui and colleagues.10 GFP expression was verified
visibly and using quantitative reverse transcriptase polymerase chain reaction
(PCR).
MSC transplantation or injection. Rabbits in the MSC trans-
plant group (group 2) received a bone marrow transplantation of labeled
MSCs. The rabbits were anesthetized and received sublethal whole body
irradiation (6 Gy) to ablate the native bonemarrow. At day 1 after radiation,
GFP-labeled autologous MSCs were delivered by ear vein injection. The1298 The Journal of Thoracic and Cardiovascular Surrabbits were kept under specific pathogen-free conditions. All transplanted
rabbits were given enrofloxacin daily during the aplasia period and human
granulocyte colony-stimulating factor for 14 days. Complete blood counts,
including platelets, reticulocytes, and differential blood counts, were ob-
tained weekly to assess whether the bone marrow had regenerated.
The rabbits receiving autologous MSC injections (group 3) had the la-
beled cells delivered intravenously at the end of the aortic implant proce-
dure by the ear vein without previous irradiation. The injections were
repeated on postoperative days 10 and 21.Anesthesia, Surgical Procedure, and Follow-up
Aortic graft harvest. Descending aortic grafts were obtained from
the euthanized rabbits under sterile surgical conditions. Matching of blood
and tissue compatibility between the recipient and donor was not attemp-
ted. As can be appreciated, the grafts lacked rigid structure and were car-
tilage free (Figure 1).
Graft interposition. Under anesthesia (intramuscular ketamine 35
mg/kg and intramuscular xylazine 10 mg/kg), the cervical trachea was dis-
sected through a median cervicotomy (Figure 1). Additional local anes-
thetic (lidocaine, solution 2%, 1 mL subcutaneously) was injected,
keeping the rabbit under spontaneous ventilation. A 1.5-cm tracheal seg-
ment was resected and replaced with the aortic allograft supported by a sil-
icone stent (2.5 cm long and 5 mm in diameter; Tracheobronxane Dumon,
Novatech, La Ciotat, France). Proximal and distal end-to-end anastomoses
were made with a 8-0 polypropylene separate stitch suture (Prolene, Ethi-
con Endo-Surgery, Blue Ash, Ohio). The stent was secured with additional
sutures, and the cervical incision was closed.
Follow-up. Buprenorphine (0.05 mg/kg, subcutaneously, 2 3 24
hours) was administered for the first 48 hours postoperatively and enroflox-
acin (10 mg/kg, intramuscularly, 23 24 hours) for 10 days postoperatively.
Clinical evaluation was performed daily. No immunosuppressive therapy
was administered.Tracheal Collection and Histologic Evaluation
Death was scheduled at 1, 3, 6, 9, 12, 15, and 18 months to explant the
grafts. En bloc resection of the trachea with surrounding tissues was per-
formed. After removal of the stent, the postmortem specimens were imme-
diately placed in a 10% formaldehyde solution. Fixed specimens were
embedded in paraffin and cut into 4-mm sections, which were stained
with hematoxylin-eosin-saffron and orcein. All dead rabbits encountered
during the follow-up period or between the euthanasia schedule underwent
a postmortem with macroscopic and microscopic examinations.In Situ Hybridization
GFP in situ hybridization. Slides from the MSC injection group
and MSC transplantation group were analyzed at 1.5, 6, 9, and 15 months
after graft implantation and at 3 weeks and 15 months, respectively.
Digoxigenin-11-UTP–labeled single-strand RNA probes were prepared
using a DIG RNA labeling kit (Roche Applied Science, Indianapolis, Ind)
according to the manufacturer’s instructions. GFP cDNAwas obtained by
PCR amplification using phosphorylated enhanced GFP plasmid (Clontech
Laboratories, Mountain View, Calif) as a template and with appropriate
primers (50GGATCCACCGGTCGCCACCAT30 and 50TCACGTTCTG
GAGCAGGACCA30). Next, the GFP PCR product was cloned in PCRII
TOPO plasmid (Invitrogen) and used to generate antisense and sense
probes. After deparaffinization, the sections were treated with 10 mg/mL
of proteinase K for 15 minutes at room temperature and subjected to
0.2 N HCl to inactivate endogenous alkaline phosphatase. Hybridization
was then performed at 50C in 50% formamide, and washes were
performed at a stringency of 23 saline sodium citrate buffer containing
50% formamide at 55C. Next, the slides were subjected to 10 mg/mL
RNase A in TNE (10 mM Tris-HCl, pH 8.0, 500 mM NaCl, and 1 mMgery c May 2013
FIGURE 1. Perioperative view showing (A) stent insertion and (B) graft implantation.
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nonhybridized transcripts and washed. The samples were incubated over-
night with anti-Dig-alkaline phosphatase. We detected the Dig probe
with nitro-blue tetrazolium chloride/5-bromo-4-chloro-30-indolyphosphate
p-toluidine salt as a substrate to give a purple/blue color. We stopped the
reaction with 3 changes of a buffer containing 1 mM ethylenediaminetetra-
acetic acid, fixed the samples with 4% paraformaldehyde/0.2% glutaralde-
hyde. These samples were mounted with Dakocytomation glycergel
(Dakocytomation, Milan, Italy) and observed under a Zeiss Axioplan 2 mi-
croscope (Carl Zeiss, le Pecq, France).
Chromosome Y fluorescence in situ hybridization on
paraffin-embedded tissue sections. Identification of cells in
the sex-mismatched grafts was studied using Y chromosome fluorescence
in situ hybridization. This technique was performed on slides from the
MSC injection group at 6 and 9 months.
The STAR*FISH rabbit Y chromosome-specific paint (Cambio, Cam-
bridge, United Kingdom)was used according to themanufacturer’s instruc-
tions. Tissue sections were deparaffinized in toluene and rehydrated in
a 100%, 95%, 70%, and 50% ethanol series, incubatedwith a sodium thio-
cyanate solution for 10minutes at 80C, and thenwashed in PBS. The slides
were secondarily subjected to a pepsin solution for 10 minutes at 37C and
quenched in a Glycin solution, before being washed again in PBS. After be-
ing fixed in a paraformaldehyde solution for 2 minutes, washes were per-
formed 3 times in PBS. Then, the slides were dehydrated through graded
alcohols and air dried. The Cambio Y-paint rabbit probe mix was warmed
to 37C, and 10 to 15 mL was applied to the center of the slides, covered
with a glass coverslip, and sealed with rubber cement. After overnight hy-
bridization at 37C, the rubber cement was peeled off and the coverslip re-
moved. The slides were then washed 3 times in formamide, 3 times in
stringency wash solution, once in a detergent wash solution, 3 times in
PBS, and mounted in Mountant (catalog no. 1124-MT-50/1250). The sam-
ples were observed under a Zeiss Axioplan 2 fluorescence microscope.RESULTS
Clinical Evaluation
In the control group (group 1), 4 of the 12 rabbits died.
Death occurred perioperatively for the first 2. The other 2
rabbits died at 1.5 months of stent migration and
obstruction.
In group 2, 2 rabbits died of whole body irradiation. An
average of 9.59 3 106 autologous MSCs was injected.
Only 10 rabbits underwent tracheal replacement, which oc-
curred at 3 months (range, 2.5-4 months) after autologous
MSC transplantation because of a prolonged neutropenia
period. Thrombocytopenia was still present in all rabbits
and resulted in moderate intraoperative bleeding. No relatedThe Journal of Thoracic and Cardeath occurred. Two rabbits died of stent migration (at 21
days and 5 months) and one of stent obstruction at 21 days.
In group 3, 2 rabbits died of unknown causes at day 1 and
day 8. Complete necropsies eliminated the cell injections as
a cause of death. An additional rabbit died of stent migra-
tion at 1.5 months.
In the postoperative period, all rabbits experienced an
irritating cough. In the case of thick secretions, short antimi-
crobial therapy (intramuscular enrofloxacin 10 mg/kg,
2 3 24 hours) was given. Because rabbit intubation was
difficult, and tracheal stent mobilization had to be avoided,
no fiberscopic aspiration was performed. Therefore, of the
32 rabbits that underwent tracheal replacement, 6 had stent
complications, including obstruction and/or migration de-
spite fixation with nonabsorbable sutures, leading to death
in all cases. During the entire follow-up period (18 months),
no anastomotic leakage, dehiscence, or stenosis was ob-
served. Most of the life-threatening events occurred at
points equivalent to the scheduled follow-up intervals,
allowing us to explant the tracheal specimens as expected
(at 1, 3, 6, 9, 12, 15, and 18 months). The results are pre-
sented in Table 1.Pathologic Findings
The macroscopic and microscopic evaluations were
quite similar in all 3 groups. Changes in graft integration
and physiology were obvious during the 18-month period.
At less than 3 months, the macroscopic examination
showed a white, thin graft that could be distinguished
from the surrounding trachea. After 3 months, the grafts
began to appear more integrated and consistently showed
a thickened aspect. By 1 year, the grafts were clearly inte-
grated and thickened in all groups. No obvious differences
could be observed macroscopically until 15 months, at
which time, macroscopic examination revealed cartilage
rings in 2 rabbits in the transplantation group (group 2;
Figure 2 and Figures E1 and E2). Contraction up to
40% (graft length measurement, 1.5 to 2 cm) was
observed after 3 months in all rabbits, but graft stenosis
was not seen under any conditions when the stent was in
good position.diovascular Surgery c Volume 145, Number 5 1299
TABLE 1. Complications and follow-up
Animal no. Death or euthanasia Complications Follow-up
Group 1
1 Death Perioperatively —
2 Death Perioperatively —
3 Death Stent migration 1.5 mo
4 Death Stent obstruction 1.5 mo
5 Euthanasia — 1 mo
6 Euthanasia — 3 mo
7 Euthanasia — 3 mo
8 Euthanasia — 5 mo
9 Euthanasia — 6 mo
10 Euthanasia — 12 mo
11 Euthanasia — 12 mo
12 Euthanasia — 18 mo
Group 2
1 Death Whole body irradiation —
2 Death Whole body irradiation —
3 Death Stent migration 21 d
4 Death Stent obstruction 21 d
5 Death Stent migration 5 mo
6 Euthanasia — 1 mo
7 Euthanasia — 1 mo
8 Euthanasia — 3 mo
9 Euthanasia — 6 mo
10 Euthanasia — 12 mo
11 Euthanasia — 15 mo
12 Euthanasia — 15 mo
Group 3
1 Death Unknown 1 d
2 Death Unknown 8 d
3 Death Stent migration 1.5 mo
4 Euthanasia — 1 mo
5 Euthanasia — 3 mo
6 Euthanasia — 3 mo
7 Euthanasia — 6 mo
8 Euthanasia — 6 mo
9 Euthanasia — 9 mo
10 Euthanasia — 15 mo
11 Euthanasia — 15 mo
Group 1, tracheal replacement alone (n ¼ 12); group 2, autologous green fluorescent
protein–labeled mesenchymal stem cell transplantation and tracheal replacement
(n ¼ 12); group 3, tracheal replacement and autologous green fluorescent protein-
labeled mesenchymal stem cell injections (n ¼ 12).
FIGURE 2. Macroscopic examination at 15 months after transplantation
group showing moderate retraction and ‘‘rings’’ over the outer surface of
graft.
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SMicroscopically, aortic tissue in the trachea location was
remodeled. Persistence of elastic fibers was present at all
stages associated with moderate inflammatory infiltrate.
By 3 months, an intact epithelial layer could be visualized
throughout the graft. In both the control and MSC injection
groups, organized collagenous and connective tissue could
be found primarily at the edges of the remodeled tissue. Ev-
idence was seen of nascent cartilage island formation at the
anastomoses of the graft in close proximity to cartilage from
the recipient but obviously within the graft, as evidenced by
the retained elastic fibers present from the aorta (Figure 3).
Secretory cells, basal cells, and glandular structures were
not fully restored in the graft (Figures E3 and E4).1300 The Journal of Thoracic and Cardiovascular SurCell contribution to graft. GFP-positive MSC contribu-
tion to structures within the allograft either after bone mar-
row transplantation of the labeled MSCs or after
intravenous injection of cells after aortic allografting was
evaluated by fluorescence in situ hybridization for EF-
GFP. MSC migration or homing to the graft was evident
throughout the evaluation period from as early as 21 days
through the end of the study period.
EF-GFP epithelial cells were present in rabbits receiving
GFP-labeled MSCs by either bone marrow transplantation
(Figure 4, A) or intravenous injection (Figure 4, E). Most
epithelial cells were GFP-positive in the rabbits receiving
a transplant, with EF-GFP cells moderately detected after
injection of labeled cells. With increased time, areas of mu-
cociliary differentiation could be seen, primarily at the edges
of the remodeled tissue growing toward the middle of the
graft, and these differentiated areas were GFP-positive. Pos-
itive cells could be seen through the connective tissue in the
graft depth (Figure 4, B). Cartilage positivity was moderate
and mostly located in the activating border. This detection
was confirmed at 6 (Figure 4, C) and 9 (Figure 4,D) months
in the injected group (Figure E5).
Hybridization in situ (fluorescent in situ hybridization)
for chromosome Y. The presence of the Y chromosome
was identified in the epithelium layer coming from the
host recipient and growing toward the middle of the graft.
The underlying organized fibrous tissue was also positive
for the Y chromosome at 6 and 9 months, showing cell inva-
sion from the host trachea (Figure 5).However, no positiveY
detection was observed in the cartilage (Figure E6).
DISCUSSION
The management of tracheal defects for which primary
end-to-end anastomosis cannot be performed remains a clin-
ical challenge. To date, the use of tissue flaps, autografts,gery c May 2013
FIGURE 3. Graft at 3 months from injection group. A, Hematoxylin-
eosin-saffron stain (original magnification 310) showing anastomosis
localization with epithelial regeneration and new cartilage in formation.
B, Orcein stain (original magnification310) showing elastic fibers within
the cartilage island.
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these methods has met with limited clinical significance
owing to a multitude of complications, such as great vessels
erosion, infection, and necrosis.1,2 Even if emerging tissue
engineering technologies offer new solutions in the future,
a tissue-engineered airway could not be considered a widely
applicable clinical treatment. Successful cases have been
reported in adults and infants11,12; however, for patients
requiring treatment now, the aortic allograft remains 1 of
the best options.3 The results obtained from different ani-
mals models (sheep, pig, rabbit, and dog) have been deemed
promising enough to be performed on humans,13 although
the mechanisms of tracheal regeneration remain unclear.
Stem cells can be found in multiple organs.14,15
Moreover, MSCs reside in virtually all postnatal organs
and tissues.16 These cells act as a reservoir of undifferenti-
ated cells to supply cellular demands of the tissue, acquiringThe Journal of Thoracic and Carlocal phenotypic characteristics. When necessary and after
signals from the microenvironment, they give rise to com-
mitted progenitors that differentiate and integrate into the
tissue.16 To explain tracheal regeneration, some reports
have suggested the presence of stem cell ‘‘niches’’ able to
give rise to a complete mucociliary epithelium after tracheal
injury.17 However, no report has been published of a specific
stem cell isolated in the trachea and leading to cartilage
regeneration. From our previous work,7-9 we hypothesized
that activation of the recipient’s multipotent MSCs
triggered by environmental signals would result in
colonization of the graft and regeneration of new trachea.
Bone marrow MSCs constitute an ideal source for cell
transplantation and tissue engineering. Complete
engraftment, mobilization, and detection of labeled MSCs
could have been negative, because many parameters need
to be controlled. Therefore, we included the MSC
injection group in our study and tested for circulating
progenitors. On the basis of the MSC circulating theory,
we hypothesized that the injured rabbits would use the
circulating MSCs, avoiding bone marrow mobilization.
Giving high pools of GFP-labeled MSCs, we increased
our chances that these cells would migrate inside the graft.
Covering of the anastomotic line by specialized respiratory
epithelium, derived from overgrowth of adjacent normal
cells with a resultant functional intraluminal lining, repre-
sents the optimal outcome after any surgical procedure on
the airway. Some investigators have shown that migration,
proliferation, and differentiation of basal and secretory cells
into ciliated cells leads to epithelial regeneration after
experimental injury of the tracheal epithelium similar to
the epithelial formation observed during the fetal stage.18
The common hypothesis proposed is the migration of basal
and mucus cells into the destroyed area, followed by forma-
tion of a mucociliary epithelium after a transitory stage of
a metaplastic epithelium.
Transplantation of female aortae into male recipients was
intentional, to enable later assessment of the graft for the
presence of the SRY gene. Positive SRY gene detection
serves as evidence of engraftment of cells derived from
the male recipient. EF-GFP detection showed the presence
of differentiated labeled cells originating from labeled
MSCs in the epithelium and connective tissue. In contrast
to some investigators,19 we found that bone marrow-
derived MSCs differentiated into epithelium of the upper
respiratory tract in rabbits. It is now recognized that the
epithelium regulates an array of airway functions, including
attraction and activation of inflammatory cells, metabolism
and clearance of inhaled agents, and regulation of airway
smooth muscle function.
We intended to track labeled MSCs in vivo to study carti-
lage regeneration inside the aortic allograft.However, noma-
ture cartilage was observed inside the graft. It was instead
present in islands at the edges of the graft (or anastomoses).diovascular Surgery c Volume 145, Number 5 1301
FIGURE 4. Hybridization in situ for theRNAofgreenfluorescent protein (GFP) for the transplanted and injectedgroups showingpositivedetectionwithin thegraft
and inside thenewcartilage.Left,Senseprobedetection; right,antisenseprobedetection.A,Graft at day21 from transplantation (originalmagnification35) showing
GFP-positive cells clearly through the epithelial layer (arrows) and at lower levels inside the graft, decreasingwith depth. B,Graft at 1.5months from injection (orig-
inalmagnification310) showingGFP-positivecells through theconnective tissue ingraftdepthunder theepithelial layer.C,Graft at6months frominjection (original
magnification310) showingGFP-positive cells in the activeborder (arrows)of recipient cartilage (asterisk)near the anastomosis.D,Graft at 9months from injection
(originalmagnification310) showingGFP-positive cells in the active border (arrows)of cartilage of recipient cartilage (asterisk) near the anastomosis. E,Graft at 15
months from injection (original magnification310) showing GFP-positive cells clearly through the epithelial layer (arrows) and at lower levels inside the graft,
decreasing with depth near cartilage (asterisk).
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FIGURE 5. Hybridization in situ for the Y chromosome for graft at Left, 6 and Right, 9 months from injection (group 2; original magnification 310).
Positive epithelial cells for the Y chromosome (arrows) can be clearly seen, as well as positive cells inside the graft. (Labeling appears as a small white
spot inside each cell.)
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did not transform into normal tracheal tissue in our rabbit
model, although the procedure was successful in pig and,
even more so, in sheep models. Several possibilities exist.
First, a species difference exists in the aortic allograft. For ex-
ample, the aortic graft is thinner in the rabbit, and it is possi-
ble that the closer orientation of the elastic fibers does not
permit cell invasion to occur. Second, gender could have
played a role. Sexual dimorphismclearly influences the func-
tion of various stem cell types throughout the body.20-22
Gender dimorphisms exist in the pathogenesis of a variety
of cardiovascular, cardiopulmonary, neurodegenerative,
and endocrine disorders. Recent studies have reported the
presence of estrogen and testosterone receptors on stem
cells, suggesting that estrogens and testosterone might
modify the function of these cells.20,21 Moreover, sex
hormones seem to play an important role in the modulation
of immune/inflammatory responses, which alter cell
mobilization, recruitment, and engraftment.22 Pig and rabbit
experiments in which the results were less positive were per-
formed on male animals, but the sheep protocols were con-
ducted on juvenile female animals. Another possibility is
that graft function drives maturation. In the smaller animal
model (rabbit), the grafts were less patent, as evidenced by
the thick secretions, coughing, and an inability to aspirate.
This decreased functionality could account for the decreased
maturation in that biomimetic environments have been
shown to drive cell phenotype and function.23
Stem cell–based therapies could be very expensive to
fully develop if they used autologous cells, because it would
be necessary to obtain a biopsy from the patient, expand the
cells in culture, perform the required testing, and store cells
before administering the therapy. An alternative approach is
the use of allogenic stem cells. Although MSCs represent
a very small fraction of the total population of nucleated
cells in the marrow, they can be isolated and expanded
with high efficiency. The use of allogenic MSCs has
many advantages, including that the donor can be chosen
in advance, qualified, tested for the absence of different dis-
ease organisms, and the MSCs prepared can be madeThe Journal of Thoracic and Caravailable in an off-the-shelf product when needed. More-
over, evidence has shown that MSCs are hypoimmuno-
genic, permitting the use of an unmatched donor, which
has broad implications in terms of allogenic therapy.24 Ad-
ditionally, several reports have described the clinical use of
allogenic donor-mismatched cells, with little evidence of
host immune rejection.25 Because stent complications can
easily be treated in human care, the mitigated results from
the rabbit model should not be viewed as a limitation for
clinical application. MSC involvement offers new perspec-
tives to accelerate the tracheal regenerative process. Future
studies using collaborative techniques (biology, tissue engi-
neering, and biomaterials) will be based on matrix compo-
nents to optimize the aortic allograft, cell mobilization and
homing to recruit autologous stem cells in the host earlier in
the regenerative process, and biomaterial technologies to
achieve functional and well-tolerated tracheal stents.
Three limitations need to be acknowledged regarding the
present study. The first limitation concerns the model. In
contrast to the sheep and pig models, cartilage regeneration
is delayed in the rabbit model and could have impaired the
results. The second limitation was the small number of rab-
bits at each point, which prevented us from giving definitive
conclusions on the tracheal regeneration process. The third
limitation concerns a technical problem: the impossibility
of placing the probe inside the cartilaginous matrix, leading
us to report negative results for Y chromosome detection.
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FIGURE E1. Macroscopic examination at 3 months for control group
showing moderate retraction and integrated graft. Arrows indicate graft
limits.
FIGURE E2. Macroscopic examination at 15 months from injection
showing moderate retraction and integrated graft. Arrows indicate graft
limits.
FIGURE E3. Graft at 3 months for control group. A, Hematoxylin-eosin-
saffron stain (original magnification 310). Epithelial regeneration
(arrows)with elastic fibers present in the deep part of graft. B, Orcein stain
(original magnification 310) for elastic fiber detection (asterisk).
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FIGURE E4. Graft at 12 months for control group showing ciliated epi-
thelial regeneration (hematoxylin-eosin-saffron stain, original magnifica-
tion 340).
FIGURE E5. Hybridization in situ for RNA of green fluorescent protein (GFP) for the transplanted and injected group showing positive detection within
the graft and inside new cartilage. Left, Sense probe detection; right, antisense probe detection. A, Graft at 1.5 months from injection (original magnification
320) showing GFP-positive cells through the connective tissue in the graft depth under epithelial layer. B, Graft at 1.5 months from injection (original
magnification 320) showing GFP-positive cells in the active border (arrows) of recipient cartilage (asterisk).
FIGURE E6. Hybridization in situ for the Y chromosome for graft at 6
months from injection (group 2; original magnification 340). Positive ep-
ithelial cells for the Y chromosome (arrow) and positive cells inside the
graft can be clearly seen. (Labeling appears as a small white spot inside
each cell.)
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